$PFE Headlines Pfizer a buy after merger talks
Post# of 72711
Posted On: 06/02/2014 3:02:29 PM
$PFE Headlines
Pfizer a buy after merger talks break down: Goldman 11:12 a.m. May 28, 2014 - Ben Eisen
Stay tuned for more drama in Pfizer-AstraZeneca saga, analysts say 3:15 p.m. May 27, 2014 - blogs.marketwatch.com
U.K. stocks up as InterContinental jumps amid bid talk 12:52 p.m. May 27, 2014 - Carla Mozee
European stocks gain, but AstraZeneca slumps 12:18 p.m. May 27, 2014 - Carla Mozee
Is the fate of the stock market in the IRS’s hands? 11:33 a.m. May 27, 2014 - Simon Constable
Newscast: Wall Street continues to gain ground 9:58 a.m. May 27, 2014 - MarketWatch
Newscast: Pfizer walks away from AstraZeneca 7:31 a.m. May 27, 2014 - MarketWatch
Pfizer walks away from AstraZeneca deal 4:02 a.m. May 27, 2014 - Geoffrey Rogow
AstraZeneca boosts FTSE 100 after two days in red 12:28 p.m. May 21, 2014 - Sara Sjolin
AstraZeneca shares creep back up amid urges to reconsider Pfizer deal 12:15 p.m. May 21, 2014 - blogs.marketwatch.com
5 value stocks for investors who fear the worst 10:14 a.m. May 21, 2014 - Philip van Doorn
The best thing about Pfizer’s failure with AstraZeneca 4:00 a.m. May 21, 2014 - Matthew Lynn
U.S. stocks gain as Apple, Russell 2000 rise 1% 5:03 p.m. May 19, 2014 - Anora Mahmudova
Newscast: Stocks open week with a win 4:33 p.m. May 19, 2014 - MarketWatch
Apple reclaims $600 mark; AT&T down on DirecTV deal 3:37 p.m. May 19, 2014 - Saumya Vaishampayan
Stocks rise for second day; small-caps, tech lead: Stock market live blog recap 3:31 p.m. May 19, 2014 - blogs.marketwatch.com
Who can afford AstraZeneca's asking price? Not many, analysts say 2:18 p.m. May 19, 2014 - blogs.marketwatch.com
Investors welcome Pfizer's latest rejection 12:34 p.m. May 19, 2014 - MarketWatch
FTSE 100 yanked lower by AstraZeneca, miners 12:31 p.m. May 19, 2014 - Sara Sjolin
AstraZeneca weighs on Stoxx 600 after rebuffing Pfizer 12:20 p.m. May 19, 2014 - Sara Sjolin
Mylan settles Celebrex patent suit 1:30 p.m. Today - Seeking Alpha
3 Stocks Advancing The Drugs Industry 1:03 p.m. Today - TheStreet.com
7 Stocks That Will Lift the Dow Jones Industrial Average to New High 12:33 p.m. Today - TheStreet.com
3 Stocks Reiterated As A Buy: PFE, UNH, OXY 9:59 a.m. Today - TheStreet.com
Today's Market: Shareholders To Push For Change At These Companies? 9:25 a.m. Today - Seeking Alpha
Mylan, Pfizer Settle on Generic Celebrex 7:44 a.m. Today - The Wall Street Journal Interactive Edition
Drug Firms Target Smaller Deals 7:21 a.m. Today - The Wall Street Journal Interactive Edition
Retirement Strategy: ETF Portfolio Vs. The Stock Only Portfolio: Surprise, Surprise! 7:30 a.m. May 31, 2014 - Seeking Alpha
When Fraud Bites Business: Lost Fortunes, Reputations and Lives 10:30 p.m. May 30, 2014 - InvestorPlace.com
Dividend Stocks Vs. Junk Bond Yields 3:32 p.m. May 30, 2014 - Seeking Alpha
Court Backs Exclusive Period for Teva's Generic Celebrex Sales 1:33 p.m. May 30, 2014 - The Wall Street Journal Interactive Edition
Dow 30 Stock Roundup: Pfizer Scraps Astrazeneca Deal, CVX Production Growth on Track - Analyst Blog 11:19 a.m. May 30, 2014 - Zacks.com
Top 10 Dow Dividend Stocks for May 10:21 a.m. May 30, 2014 - InvestorPlace.com
Teva gets favorable court ruling on generic Celebrex 9:28 a.m. May 30, 2014 - Seeking Alpha
Pfizer: Why A Major Acquisition Or Break-Up Is Needed 8:47 a.m. May 30, 2014 - Seeking Alpha
Elelyso gets the nod in Canada 7:52 a.m. May 30, 2014 - Seeking Alpha
Actavis, Forest CEOs Team Up To Lead New Drug Giant 3:47 p.m. May 29, 2014 - Investors Business Daily
Sanofi-Eli Lilly Collaborate for OTC Cialis - Analyst Blog 1:50 p.m. May 29, 2014 - Zacks.com
Dow Today: Pfizer (PFE) Higher 11:00 a.m. May 29, 2014 - TheStreet.com
IHG Faces Pressure to Seek Merger 9:38 a.m. May 29, 2014 - The Wall Street Journal Interactive Edition
Mylan Settles Patent Litigation Related to Celebrex® Capsules 7:00 a.m. Today - PR Newswire - PRF
Dr. Morris J. Birnbaum Joins Pfizer as Chief Scientific Officer, Cardiovascular and Metabolic Disease Research 11:14 a.m. May 29, 2014 - BusinessWire - BZX
Retrophin Names Alvin Shih, M.D. Executive Vice President of Research and Development 8:30 a.m. May 29, 2014 - BusinessWire - BZX
ACETO Subsidiary, Rising Pharmaceuticals, Has Launched the Generic Version of Pfizer Inc.'s Diflucan(R) 4:06 p.m. May 27, 2014 - GlobeNewswire
Must Watch News: Pfizer Inc, AT&T, Alpha Natural Resources, Sprint Corporation 9:06 a.m. May 27, 2014 - ACCESSWIRE
Pfizer BringsFrequent Heartburn ReliefOver-the-Counter with New Nexium® 24HR 8:31 a.m. May 27, 2014 - BusinessWire - BZX
Favorable Support, NDA Submission, Conference Schedule, Acquisition Update, and Executive Appointment - Analyst Notes on Allergan, Pfizer, Eli Lilly, Forest and Pharmacyclics 7:20 a.m. May 27, 2014 - PR Newswire - PRF
Statement from Pfizer Inc. 10:05 a.m. May 26, 2014 - BusinessWire - BZX
Pfizer Announces Detailed Results For Phase 3 OPT Retreatment Study Of Tofacitinib In Adults With Moderate-To-Severe Chronic Plaque Psoriasis 9:13 a.m. May 23, 2014 - BusinessWire - BZX
BioRestorative Therapies Signs Research Agreement with Pfizer Inc. 8:01 a.m. May 22, 2014 - BusinessWire - BZX
Nanomedicine Market (Neurology, Cardiovascular, Anti-inflammatory, Anti-infective, and Oncology Applications) - Global Industry Analysis, Size, Share,Growth, Trends and Forecast, 2013 - 2019 11:59 a.m. May 21, 2014 - PR Newswire - PRF
Chemotherapy Induced Peripheral Neuropathy Global Clinical Trials Review, H1, 2014 11:40 a.m. May 21, 2014 - PR Newswire - PRF
New Survey Highlights The Impact Of Menopausal Symptoms On Women In The Workplace 8:15 a.m. May 21, 2014 - BusinessWire - BZX
GlycoMimetics Receives $15 Million Payment from Pfizer in Connection with Planned Initiation of Phase 3 Trial 4:01 p.m. May 20, 2014 - BusinessWire - BZX
Statement from Pfizer Inc. 6:41 p.m. May 19, 2014 - BusinessWire - BZX
Senesco Completes Acquisition of Fabrus 8:31 a.m. May 19, 2014 - BusinessWire - BZX
Semi-Annual Changes to the NASDAQ OMX CRD Global Sustainability Index 8:05 a.m. May 19, 2014 - GlobeNewswire
Pfizer Makes Final Proposal to AstraZeneca 5:03 p.m. May 18, 2014 - BusinessWire - BZX
Pfizer To Submit Palbociclib New Drug Application With FDA Based On Final Results Of PALOMA-1 12:12 p.m. May 16, 2014 - BusinessWire - BZX
FDA Approvals, Stock Price Updates, and Financial Results Release - Analyst Notes on Pfizer, Actavis, Pharmacyclics, Mallinckrodt and Salix Pharmaceuticals 7:40 a.m. May 16, 2014 - PR Newswire - PRF
Pfizer a buy after merger talks break down: Goldman 11:12 a.m. May 28, 2014 - Ben Eisen
Stay tuned for more drama in Pfizer-AstraZeneca saga, analysts say 3:15 p.m. May 27, 2014 - blogs.marketwatch.com
U.K. stocks up as InterContinental jumps amid bid talk 12:52 p.m. May 27, 2014 - Carla Mozee
European stocks gain, but AstraZeneca slumps 12:18 p.m. May 27, 2014 - Carla Mozee
Is the fate of the stock market in the IRS’s hands? 11:33 a.m. May 27, 2014 - Simon Constable
Newscast: Wall Street continues to gain ground 9:58 a.m. May 27, 2014 - MarketWatch
Newscast: Pfizer walks away from AstraZeneca 7:31 a.m. May 27, 2014 - MarketWatch
Pfizer walks away from AstraZeneca deal 4:02 a.m. May 27, 2014 - Geoffrey Rogow
AstraZeneca boosts FTSE 100 after two days in red 12:28 p.m. May 21, 2014 - Sara Sjolin
AstraZeneca shares creep back up amid urges to reconsider Pfizer deal 12:15 p.m. May 21, 2014 - blogs.marketwatch.com
5 value stocks for investors who fear the worst 10:14 a.m. May 21, 2014 - Philip van Doorn
The best thing about Pfizer’s failure with AstraZeneca 4:00 a.m. May 21, 2014 - Matthew Lynn
U.S. stocks gain as Apple, Russell 2000 rise 1% 5:03 p.m. May 19, 2014 - Anora Mahmudova
Newscast: Stocks open week with a win 4:33 p.m. May 19, 2014 - MarketWatch
Apple reclaims $600 mark; AT&T down on DirecTV deal 3:37 p.m. May 19, 2014 - Saumya Vaishampayan
Stocks rise for second day; small-caps, tech lead: Stock market live blog recap 3:31 p.m. May 19, 2014 - blogs.marketwatch.com
Who can afford AstraZeneca's asking price? Not many, analysts say 2:18 p.m. May 19, 2014 - blogs.marketwatch.com
Investors welcome Pfizer's latest rejection 12:34 p.m. May 19, 2014 - MarketWatch
FTSE 100 yanked lower by AstraZeneca, miners 12:31 p.m. May 19, 2014 - Sara Sjolin
AstraZeneca weighs on Stoxx 600 after rebuffing Pfizer 12:20 p.m. May 19, 2014 - Sara Sjolin
Mylan settles Celebrex patent suit 1:30 p.m. Today - Seeking Alpha
3 Stocks Advancing The Drugs Industry 1:03 p.m. Today - TheStreet.com
7 Stocks That Will Lift the Dow Jones Industrial Average to New High 12:33 p.m. Today - TheStreet.com
3 Stocks Reiterated As A Buy: PFE, UNH, OXY 9:59 a.m. Today - TheStreet.com
Today's Market: Shareholders To Push For Change At These Companies? 9:25 a.m. Today - Seeking Alpha
Mylan, Pfizer Settle on Generic Celebrex 7:44 a.m. Today - The Wall Street Journal Interactive Edition
Drug Firms Target Smaller Deals 7:21 a.m. Today - The Wall Street Journal Interactive Edition
Retirement Strategy: ETF Portfolio Vs. The Stock Only Portfolio: Surprise, Surprise! 7:30 a.m. May 31, 2014 - Seeking Alpha
When Fraud Bites Business: Lost Fortunes, Reputations and Lives 10:30 p.m. May 30, 2014 - InvestorPlace.com
Dividend Stocks Vs. Junk Bond Yields 3:32 p.m. May 30, 2014 - Seeking Alpha
Court Backs Exclusive Period for Teva's Generic Celebrex Sales 1:33 p.m. May 30, 2014 - The Wall Street Journal Interactive Edition
Dow 30 Stock Roundup: Pfizer Scraps Astrazeneca Deal, CVX Production Growth on Track - Analyst Blog 11:19 a.m. May 30, 2014 - Zacks.com
Top 10 Dow Dividend Stocks for May 10:21 a.m. May 30, 2014 - InvestorPlace.com
Teva gets favorable court ruling on generic Celebrex 9:28 a.m. May 30, 2014 - Seeking Alpha
Pfizer: Why A Major Acquisition Or Break-Up Is Needed 8:47 a.m. May 30, 2014 - Seeking Alpha
Elelyso gets the nod in Canada 7:52 a.m. May 30, 2014 - Seeking Alpha
Actavis, Forest CEOs Team Up To Lead New Drug Giant 3:47 p.m. May 29, 2014 - Investors Business Daily
Sanofi-Eli Lilly Collaborate for OTC Cialis - Analyst Blog 1:50 p.m. May 29, 2014 - Zacks.com
Dow Today: Pfizer (PFE) Higher 11:00 a.m. May 29, 2014 - TheStreet.com
IHG Faces Pressure to Seek Merger 9:38 a.m. May 29, 2014 - The Wall Street Journal Interactive Edition
Mylan Settles Patent Litigation Related to Celebrex® Capsules 7:00 a.m. Today - PR Newswire - PRF
Dr. Morris J. Birnbaum Joins Pfizer as Chief Scientific Officer, Cardiovascular and Metabolic Disease Research 11:14 a.m. May 29, 2014 - BusinessWire - BZX
Retrophin Names Alvin Shih, M.D. Executive Vice President of Research and Development 8:30 a.m. May 29, 2014 - BusinessWire - BZX
ACETO Subsidiary, Rising Pharmaceuticals, Has Launched the Generic Version of Pfizer Inc.'s Diflucan(R) 4:06 p.m. May 27, 2014 - GlobeNewswire
Must Watch News: Pfizer Inc, AT&T, Alpha Natural Resources, Sprint Corporation 9:06 a.m. May 27, 2014 - ACCESSWIRE
Pfizer BringsFrequent Heartburn ReliefOver-the-Counter with New Nexium® 24HR 8:31 a.m. May 27, 2014 - BusinessWire - BZX
Favorable Support, NDA Submission, Conference Schedule, Acquisition Update, and Executive Appointment - Analyst Notes on Allergan, Pfizer, Eli Lilly, Forest and Pharmacyclics 7:20 a.m. May 27, 2014 - PR Newswire - PRF
Statement from Pfizer Inc. 10:05 a.m. May 26, 2014 - BusinessWire - BZX
Pfizer Announces Detailed Results For Phase 3 OPT Retreatment Study Of Tofacitinib In Adults With Moderate-To-Severe Chronic Plaque Psoriasis 9:13 a.m. May 23, 2014 - BusinessWire - BZX
BioRestorative Therapies Signs Research Agreement with Pfizer Inc. 8:01 a.m. May 22, 2014 - BusinessWire - BZX
Nanomedicine Market (Neurology, Cardiovascular, Anti-inflammatory, Anti-infective, and Oncology Applications) - Global Industry Analysis, Size, Share,Growth, Trends and Forecast, 2013 - 2019 11:59 a.m. May 21, 2014 - PR Newswire - PRF
Chemotherapy Induced Peripheral Neuropathy Global Clinical Trials Review, H1, 2014 11:40 a.m. May 21, 2014 - PR Newswire - PRF
New Survey Highlights The Impact Of Menopausal Symptoms On Women In The Workplace 8:15 a.m. May 21, 2014 - BusinessWire - BZX
GlycoMimetics Receives $15 Million Payment from Pfizer in Connection with Planned Initiation of Phase 3 Trial 4:01 p.m. May 20, 2014 - BusinessWire - BZX
Statement from Pfizer Inc. 6:41 p.m. May 19, 2014 - BusinessWire - BZX
Senesco Completes Acquisition of Fabrus 8:31 a.m. May 19, 2014 - BusinessWire - BZX
Semi-Annual Changes to the NASDAQ OMX CRD Global Sustainability Index 8:05 a.m. May 19, 2014 - GlobeNewswire
Pfizer Makes Final Proposal to AstraZeneca 5:03 p.m. May 18, 2014 - BusinessWire - BZX
Pfizer To Submit Palbociclib New Drug Application With FDA Based On Final Results Of PALOMA-1 12:12 p.m. May 16, 2014 - BusinessWire - BZX
FDA Approvals, Stock Price Updates, and Financial Results Release - Analyst Notes on Pfizer, Actavis, Pharmacyclics, Mallinckrodt and Salix Pharmaceuticals 7:40 a.m. May 16, 2014 - PR Newswire - PRF
(0)
(0)Scroll down for more posts ▼